IPP Bureau

BD, Suttons Creek partner to streamline combination product development
BD, Suttons Creek partner to streamline combination product development

By IPP Bureau - April 30, 2026

The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration

RPG Life Sciences reports Rs 707.5 crore revenue in FY26, 8% annual growth
RPG Life Sciences reports Rs 707.5 crore revenue in FY26, 8% annual growth

By IPP Bureau - April 30, 2026

In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth

GSK wins regulatory boost for once-monthly liver drug efimosfermin in MASH push
GSK wins regulatory boost for once-monthly liver drug efimosfermin in MASH push

By IPP Bureau - April 30, 2026

The twin designations are designed to speed up the development and review of promising medicines targeting serious conditions with high unmet need

Syngene reports FY26 revenue of Rs 3,739 Cr, up 3%; Q4 revenue at Rs 1,037 Cr
Syngene reports FY26 revenue of Rs 3,739 Cr, up 3%; Q4 revenue at Rs 1,037 Cr

By IPP Bureau - April 30, 2026

Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities

Sahajanand Medical Technologies secures ISO 50001:2018 certification for Surat, Hyderabad facilities
Sahajanand Medical Technologies secures ISO 50001:2018 certification for Surat, Hyderabad facilities

By IPP Bureau - April 30, 2026

Certification reinforces energy efficiency, sustainability goals, and green manufacturing across SMT’s Surat and Hyderabad facilities

Solara announces closure of US FDA inspection at Puducherry facility
Solara announces closure of US FDA inspection at Puducherry facility

By IPP Bureau - April 30, 2026

The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets

Wanbury's Patalganga site clears Korea FDA inspection with zero observations
Wanbury's Patalganga site clears Korea FDA inspection with zero observations

By IPP Bureau - April 30, 2026

Patalganga plant received zero observation from USFDA earlier

KIMS enters into MoU for strategic clinical collaboration
KIMS enters into MoU for strategic clinical collaboration

By IPP Bureau - April 30, 2026

The association is intended to strengthen healthcare delivery standards, particularly in Oncology services, and enhance patient care outcomes

Pfizer drug delivers breakthrough in late-stage blood cancer trial
Pfizer drug delivers breakthrough in late-stage blood cancer trial

By IPP Bureau - April 30, 2026

Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis

Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout
Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout

By IPP Bureau - April 30, 2026

The agreement could rise to $900 million if key commercial milestones are met

Zealand Pharma and Roche charge into Phase 3 with obesity drug bet
Zealand Pharma and Roche charge into Phase 3 with obesity drug bet

By IPP Bureau - April 30, 2026

The Danish biotech company confirmed the global study will begin in the second half of 2026

Gen Z split on AI as global study reveals rising tech optimism
Gen Z split on AI as global study reveals rising tech optimism

By IPP Bureau - April 30, 2026

Health innovations are viewed more positively than food and agricultural technologies

CPHI & PMEC India 2026 expand to dual venues in Delhi NCR
CPHI & PMEC India 2026 expand to dual venues in Delhi NCR

By IPP Bureau - April 30, 2026

CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart

Monitra Health raises fresh funding  to scale upBeat® cardiac monitoring platform globally
Monitra Health raises fresh funding to scale upBeat® cardiac monitoring platform globally

By IPP Bureau - April 30, 2026

The medtech firm strengthens its full-stack remote cardiac monitoring platform, achieves 11x revenue growth, and advances its global expansion plans

Eli Lilly flags counterfeit Mounjaro products in Gurugram, backs regulatory action
Eli Lilly flags counterfeit Mounjaro products in Gurugram, backs regulatory action

By IPP Bureau - April 30, 2026

Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies

Latest Stories

Interviews

Packaging